Hormonal Contraceptive Eligibility for Women at High Risk of HIV The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was...
ECHO Management Committee on New WHO Guidance on Use of Hormonal Contraceptives by Women at High Risk of HIV Statement by the ECHO Management Committee on the new WHO guidance on use of hormonal contraceptives by women at high risk of HIV. ...
WHO Statement on Depot-medroxyprogesterone acetate (DMPA) The purpose of this Statement is to reiterate and clarify the existing (current) WHO position based on published guidance that is still valid. WHO monitors the evidence in this field closely and will update its...
Hormonal Contraceptive Methods for Women at High Risk of HIV and Living with HIV 2014 Guidance Statement In addition to the recommendations themselves, this publication provides a description of the background and methods used in their development. ...
Collaborative Statement from Women’s Health Advocates from WHO and Partners Stakeholders’ Meeting on Hormonal Contraception and HIV This is a collaborative statement from women’s health advocates from a WHO and partners’ stakeholders’ meeting...
Recent Comments